Does Plasminogen Activator Inhibitor-1 Drive Lymphangiogenesis?

Françoise Bruyère, Laurence Melen-Lamalle, Silvia Blacher et al. · 2010

Read Does Plasminogen Activator Inhibitor-1 Drive Lymphangiogenesis? by Françoise Bruyère, Laurence Melen-Lamalle, Silvia Blacher et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0009653.txt.

Description

Francoise Bruyere and co-authors asked whether a clotting protein also builds lymph vessels in PLOS ONE in 2010. The protein is PAI-1. Its known job is to slow the breakdown of blood clots. Lymph vessels drain fluid from tissues and carry immune cells. Their growth is called lymphangiogenesis. The team tested whether PAI-1 drives that growth.

Experiments in their model weighed the protein's effect on new lymph vessel formation. A familiar clotting factor moonlighting in vessel building would link two systems. The question matters for cancer, since tumors use lymph vessels to spread. It also matters for swelling disorders where drainage fails.

Catalog record

CREATORFrançoise Bruyère, Laurence Melen-Lamalle, Silvia Blacher et al.
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE39 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0009653

Browse the full library · About the Tower of Babel